Delivery Order 75N94024D00003-75N94024F00001
Award Date 9/30/24
Potential Completion Date 9/29/29
Potential Value $15K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $158,877.60 firm fixed price contract is for the provision of metabolic isotopes, a non-severable service, with a performance period ending on April 13, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing...
- This is a $22,303.20 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a small business based in Tonawanda, New York. The contract is for the acquisition of an intravenous stable isotope, which is likely a specialized pharmaceutical product used in metabolic and clinical research studies conducted by NIDDK and other HHS...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- The National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases has awarded a $15,400 firm fixed price purchase order to Pine Pharmaceuticals LLC. The contract is for the delivery of 6,6 D2Glucose intravenous stable isotopes to support metabolic research studies being conducted by NIDDK in Tonawanda, New York. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in high-quality pharmaceutical compounds and repackaged products, with...
- This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
- This is a $125,812.80 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the acquisition of intravenous stable isotopes, specifically 6,6 deuterated glucose and d5 glycerol, to support metabolic research conducted by NIDDK. The contract was awarded on a non-competitive, sole-source basis, as Pine Pharmaceuticals is the only approved...
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- The Department of Veterans Affairs Veterans Integrated Service Network 23 awarded a $29,031 delivery order to Pine Pharmaceuticals LLC on October 1, 2025, for 503B compounding pharmaceuticals. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Tonawanda, New York. Pine Pharmaceuticals, an FDA-registered 503B outsourcing facility with over 37 years of operational...
- This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...